Buoyed by $110m in funding three months ago, Capstan Medical has reported the first-in-human cases with the mitral technology.
Led by Boston Scientific, the funding will expedite the clinical development and commercialisation of 4C Medical’s transcatheter mitral valve replacement (TMVR) technology, AltaValve System. Piper ...
“Skyven Arcturus, built on mechanical vapor recompression (MVR) technology, uses electricity to upgrade low-temperature heat captured from industrial processes and uses that heat to produce ...
4C Medical Technologies Inc. raised $175 million in a series D financing round led by Boston Scientific Corp. The financing will support the regulatory trials and commercialization of the Altavalve ...